5 of the Best New Stocks of Q2 2014

These IPO hits have run off returns of more than 70% in just a few short months

       

Best New Stocks of Q2 – #4, Alder Biopharmaceuticals (ALDR)

alder biopharmaceuticals aldr 185 5 of the Best New Stocks of Q2 2014Return: 76%

At its onset, Alder Biopharmaceuticals (ALDR) didn’t look like it would make any list of top new stocks, managing to post a meager 0.3% return on its first day of trading.

Since then, ALDR has been on fire.

Alder is building a proprietary antibody platform, MabXpress, to better target diseases not addressed by antibodies. ALDR’s lead drugs treat rheumatoid arthritis and provide for migraine treatments, both massive market opportunities.

Alder also has a strong backing, as it has forged a major collaboration with Bristol-Myers Squibb (BMY) for its drug Clazakizumab, for rheumatoid arthritis.

Next Page


Article printed from InvestorPlace Media, http://investorplace.com/ipo-playbook/5-best-new-stocks-ipos/.

©2014 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.